OncoHost’s Focus On The Patient Offers Precision Oncology To Combat Cancer
OncoHost's platform combines proteomic analysis with AI to predict host responses to immunotherapy, and gain insight into cancer treatments.
July 06, 2021
Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform
Oncohost developed a platform to identify key biological processes and proteins that drive response in patients undergoing cancer treatment.
January 19, 2021
First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel
OncoHost, an Israeli company using response profiling to improve personalized cancer therapy, announced last week it has opened a new state-of-the-art high throughput proteomics laboratory for analysis of host response to cancer treatment. Proteomics, or proteomic analysis, refers to the systematic identification and quantification of the complete complement of proteins (the proteome) of a biological […]
December 08, 2019